Randomized, double-blind, placebo-controlled trial of bovine lactoferrin in patients with chronic hepatitis C-Reference-Cited by-同舟云学术

Randomized, double-blind, placebo-controlled trial of bovine lactoferrin in patients with chronic hepatitis C

Published:2006-10 Issue:10 Volume:97 Page:1105-1110
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Ueno Hideki,Sato Tosiya,Yamamoto Seiichiro,Tanaka Katsuaki,Ohkawa Shinichi,Takagi Hitoshi,Yokosuka Osamu,Furuse Junji,Saito Hidetsugu,Sawaki Akira,Kasugai Hiroshi,Osaki Yukio,Fujiyama Shigetoshi,Sato Keiko,Wakabayashi Keiji,Okusaka Takuji

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2006.00274.x/fullpdf

Reference33 articles.

1. Natural history of liver fibrosis progression in patients with chronic hepatitis C

2. Hepatocellular Carcinoma Associated with Hepatitis C Virus Infection in Japan: Projection to Other Countries in the Foreseeable Future

3. Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of bovine dairy products and their components on the incidence and natural history of infection: a systematic literature review;Nutrition Journal;2024-02-27

2. Antimicrobial peptides for novel antiviral strategies in the current post‐COVID‐19 pandemic;Journal of Peptide Science;2023-07-28

3. An overview on in vitro and in vivo antiviral activity of lactoferrin: its efficacy against SARS-CoV-2 infection;BioMetals;2022-08-03

4. The Influence of Viral Infections on Iron Homeostasis and the Potential for Lactoferrin as a Therapeutic in the Age of the SARS-CoV-2 Pandemic;Nutrients;2022-07-27

5. Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences;Frontiers in Pharmacology;2021-06-17